Navigation Links
Global Immunology Market Will Hit $74.2 Billion by 2022, says GBI Research
Date:1/28/2016

LONDON, January 28, 2016 /PRNewswire/ --

A new report from business intelligence provider GBI Research - Global Immunology Market to 2022 - states that the global immunology treatment market is set to expand from the $61.5 billion in 2015 to an estimated $74.2 billion in 2022, despite the imminent expiry of a host of immunology treatments.

The immunology therapeutic arena's Compound Annual Growth Rate (CAGR) will equal a relatively stable 2.71%, due to practical and regulatory barriers to entry for biosimilars that are not present for small molecule generics, and a moderately strong late-stage pipeline.

Managing Analyst Dominic Trewartha says: "This market is a lucrative area as up to 7% of western populations are thought to be affected by chronic immunological disorders. Consequently, the pharmaceutical pipeline for immunology is considerable, with 1,896 products currently in active development.

"While 85 of these are in Phase III of the process, it must be acknowledged that 73% of these pipeline products are in early developmental stages."

GBI Research's study suggests there are a number of prospective products expected to achieve strong annual revenues during the forecast period, although these are not anticipated to achieve revenues comparable to those generated by the current strongest-selling immunology products.

Trewartha explains: "To date, the most clinically and commercially effective drugs have been in a class of compounds known as monoclonal Antibodies (mAbs), which includes blockbuster products such as Humira (adalimumab) and Remicade (infliximab).

"APB-501, a biosimilar of Humira, which was the best-selling drug of 2014 worldwide, is anticipated to generate annual revenues of almost $1 billion by 2022, making it an exceptionally strong-performing non-patented drug."

The analyst adds that while the immunology therapeutics market is a very commercially active area, with a number of exceptionally high-selling products present, revenues for these key drugs are expected to undergo a steady decline towards the end of the period.

Trewartha concludes: "GBI Research believes that revenues for immunology therapeutics will only significantly decline in the long term, beyond the forecast period. This is due to the protective effect of the practical and regulatory challenges in fielding biosimilar products, which reduces the impact of patent expiries on biologics, compared with small molecules."

Sample pages of GBI Research's report Global Immunology Market to 2022 are available upon request

About GBI Research 

GBI Research is a leading provider of business intelligence reports, offering actionable data and forecasts based on the insights of key healthcare industry influencers to ensure you stay up-to-date with the latest market trends. For more information about our offerings, please contact us on: +44-161-359-5817

Connect with GBI Research on social media for the latest healthcare market updates:Facebook | LinkedIn | Twitter


'/>"/>
SOURCE GBI Research
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
2. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
3. Global Regulatory Milestones for Invibio Biomaterial Solutions
4. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
5. Global Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) - 2013 Market Report
6. Lucintel's Analysis of Global Catalysts Industry: Chemical and Automobile Industries Play Crucial Role in Growth
7. Global Biochips and Microarrays 2013 Market Report
8. Global Bio-implants Market 2012-2016 New Research Report Now Available at MarketResearchReports.biz
9. USP Global Fellowship Awards Program Call for Applications
10. Medical Gases and Equipment Market is Expected to Reach USD 9 Billion Globally in 2018: Transparency Market Research
11. Global Food Safety Testing Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2019)... ... May 15, 2019 , ... Milton Hershey School® has named William Charles ... within the biomedical industry, where he is changing lives by creating solutions to global ... Harding epitomizes the vision of our founders – Milton and Catherine Hershey – who ...
(Date:5/14/2019)... , ... May 14, 2019 , ... Gateway Genomics ... effectively doubling its space from 2,500 to 5,000 square feet. , “This past ... DNA tests ,” says Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home test, which ...
(Date:5/4/2019)... ... May 03, 2019 , ... More than three ... Pesquisas Association, the scientist and ufologist Urandir Fernandes de Oliveira, last Thursday (25), ... the results of some research carried out by the association, in partnership with ...
(Date:5/2/2019)... ... 2019 , ... The centuries old practice of brewing beer thrives today across ... and even home brewing clubs scattered across the nation. , But proper beer ... can produce a superb product. Students at South Dakota School of Mines & ...
Breaking Biology Technology:
(Date:5/24/2019)... , ... May 24, 2019 , ... The newest edition ... is now available on the company’s global website. , Crystallography Times is a monthly ... X-ray diffraction. It serves the X-ray analysis community by presenting the latest news and ...
(Date:5/23/2019)... , ... May 23, 2019 , ... ... Agents for sales and service organizations, today announced its inclusion in DMG ... Solutions as the intelligent virtual agent (IVA) market share leader, based on number ...
(Date:5/21/2019)... ... May 21, 2019 , ... Experiential tourism, a trend encompassing culinary travel, ... last several years. And according to a recent report by Skift, a media ... fact, more and more travelers are wanting their journeys to be authentic and unique, ...
Breaking Biology News(10 mins):